PubRank

C D Short

Author PubWeight™ 34.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Sequential development of systemic vasculitis with anti-neutrophil cytoplasmic antibodies complicating anti-glomerular basement membrane disease. Clin Nephrol 1989 1.63
2 Serum lipoprotein (a) in renal transplant recipients receiving cyclosporin monotherapy. Nephrol Dial Transplant 1993 1.42
3 Long-term outcome of adult-onset minimal-change nephropathy. Nephrol Dial Transplant 1996 1.39
4 Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol 1989 1.24
5 Cytokine gene polymorphisms predict acute graft rejection following renal transplantation. Kidney Int 1999 1.11
6 Recurrence of light chain nephropathy in a renal allograft. A case report and review of the literature. Am J Nephrol 2001 1.00
7 Long-term follow-up of drusen-like lesions in patients with type II mesangiocapillary glomerulonephritis. Br J Ophthalmol 2008 0.99
8 Clinical membranous nephropathy. Nephron 1983 0.95
9 Gm allotypes in membranous nephropathy. N Engl J Med 1983 0.94
10 Comparative mortality from cardiovascular disease in patients with chronic renal failure. Nephrol Dial Transplant 1994 0.91
11 Urinary C5b-9 excretion and clinical course in idiopathic human membranous nephropathy. Kidney Int 1995 0.91
12 Complete clinical remission and subsequent relapse of bronchiectasis-related (AA) amyloid induced nephrotic syndrome. Nephron 1996 0.86
13 The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol 2000 0.84
14 Reduction in gingival overgrowth associated with conversion from cyclosporin A to tacrolimus. J Clin Periodontol 2000 0.84
15 Transforming growth factor beta 1 in renal allograft recipients. Transplantation 1994 0.84
16 Plasma transforming growth factor beta(1) and platelet activation: implications for studies in transplant recipients. Nephrol Dial Transplant 2001 0.84
17 Serum and urine IL-6 and TNF-alpha in renal transplant recipients with graft dysfunction. Transplantation 1993 0.83
18 The nephrotic syndrome and ischaemic heart disease. Nephron 1981 0.83
19 Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation. Nephron 1997 0.83
20 Urinary C3dg and C5b-9 indicate active immune disease in human membranous nephropathy. Kidney Int 1992 0.83
21 How far since Ellis? The Manchester Study of glomerular disease. Nephron 1987 0.82
22 Serum and urinary high density lipoproteins in glomerular disease with proteinuria. Kidney Int 1986 0.81
23 Effects of the calcium-channel agonist CGP 28392 on insulin secretion from isolated rat islets of Langerhans. Biochem J 1985 0.81
24 Impaired IgG response to tetanus toxoid in human membranous nephropathy: association with HLA-DR3. Clin Exp Immunol 1986 0.80
25 Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int 1988 0.79
26 Campylobacter jejuni enteritis and reactive arthritis. Ann Rheum Dis 1982 0.79
27 Hyperlipidaemia and renal disease. Baillieres Clin Endocrinol Metab 1990 0.79
28 Familial membranous nephropathy. Br Med J (Clin Res Ed) 1984 0.78
29 Minimal-change nephropathy: how does the immune system affect the glomerulus? Nephrol Dial Transplant 1993 0.78
30 Tacrolimus is not associated with gingival overgrowth in renal transplant patients. J Clin Periodontol 2001 0.77
31 The temporal relationship between urinary C5b-9 and C3dg and clinical parameters in human membranous nephropathy. Nephrol Dial Transplant 1993 0.77
32 The influence of transforming growth factor-beta1 gene polymorphisms on the severity of gingival overgrowth associated with concomitant use of cyclosporin A and a calcium channel blocker. J Periodontol 2001 0.77
33 Oncocytic and oncocytoid tumors of the salivary glands. Laryngoscope 1973 0.77
34 Is persistent TGFbeta1 expression the mechanism responsible for chronic renal allograft loss? Nephrol Dial Transplant 1998 0.77
35 HLA antigen and gene polymorphisms and haplotypes established by family studies in membranous nephropathy. Nephrol Dial Transplant 1992 0.76
36 Towards defining antigens in human membranous nephropathy. Nephrol Dial Transplant 1992 0.76
37 Relapsing idiopathic membranous nephropathy. Clin Nephrol 1982 0.75
38 Fundus changes in mesangiocapillary glomerulonephritis type II: vitreous fluorophotometry. Br J Ophthalmol 1989 0.75
39 Transfusion-induced hyperkalemia. Anesthesiology 1991 0.75
40 Heavy proteinuria following urinary diversion. Postgrad Med J 1984 0.75
41 Factors influencing kidney transplantation in Manchester, UK: 1989-1996. Clin Transpl 1997 0.75
42 Renal manifestations of systemic disorders. Practitioner 1981 0.75
43 Pyrophosphate phosphohydrolase in mammary tissue of pregnant and lactating rats. Endocrinology 1967 0.75
44 Twenty-one years survival with systemic AL-amyloidosis. Am J Kidney Dis 1996 0.75
45 Strategies for meaningful measurement of circulating levels of transforming growth factor beta1 in clinical samples. Transplantation 2001 0.75
46 Banff criteria as predictors of outcome following acute renal allograft rejection. Nephrol Dial Transplant 1999 0.75
47 Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993 0.75
48 Pancreatic tuberculosis following renal transplantation. Nephron 1992 0.75
49 Equine dermatophilosis: a two-year clinico-pathologic study. Vet Med Small Anim Clin 1974 0.75
50 Th1 and Th2 cytokine gene expression in human renal allografts. Transplant Proc 1995 0.75
51 Clinical audit and long-term evaluation of renal transplant recipients. Transplantation 2001 0.75
52 Ischaemic heart disease, lipids and the kidney. Contrib Nephrol 1993 0.75
53 Intoxication by aspirin and alcohol in a child. A case of child abuse by medical neglect. Am J Forensic Med Pathol 1983 0.75
54 Late cellular rejection in renal transplant recipients. Transplantation 1986 0.75
55 Recent approaches to understanding clinical glomerular disease. Ren Fail 1996 0.75
56 Tacrolimus monotherapy in renal transplantation: four-year data. Transplant Proc 2002 0.75
57 Clinical aspects of C3dg and C5b-9 in human membranous nephropathy. Nephrol Dial Transplant 1992 0.75
58 Diagnosis of disease in renal allografts: correlation between ultrasound and histology. Clin Radiol 1986 0.75
59 Magnetic resonance imaging in non-infective destructive spondyloarthropathy. Br J Radiol 1988 0.75